Immune recovery in HIV with mycobacterium W

Journal of the Indian Medical Association

Volumn 100, Issue 9, 2002, Pages 578-579

  Kharkar, Rajendra ^a  

^a NONE

Author keywords

CD4 count; HIV; Immune recovery; Immunomodulator; Mycobacterium w

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; IMMUNOMODULATING AGENT; MYCOBACTERIUM VACCINE; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TOLERABILITY; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNITY; LYMPHOCYTE DEPLETION; MYCOBACTERIUM W; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

EID: 0036755295     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, et al - Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA 2000; 283.381-90.
2. Fauci AS, Barlett JO, Goosby EP, Kates J - Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at http:/www.hivatis.org (August, 2001)
3. Wilkinson J, Gotch F - Immune interventions. Br Med Bull 2001;58:187-203.
4. Levy Y, Capitant C, Houhou S, Carriere I, Viard JP, Goujard C, et al -Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 Study Group. Lancet 1999; 353 (9168):1923-9.
5. Talwar GP - An immunotherapeutic vaccine for multibacillary leprosy. Int Rev Immunol 1999;18:229-49.
6. Vandamme AM, Van Laethem K, De Clercq E - Managing resistance to anti-HIV drugs: an important consideration for effective disease management. Drugs 1999;57:337-61.